Company intelligence / Profile preview

Olympus Capital Asia

Hong Kong, Hong Kong

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Olympus Capital Asia is an independent private equity firm that specializes in middle-market investments across the Asia-Pacific region. Established in 1997, the firm operates a dedicated healthcare vertical, Olympus Capital Asia Healthcare (OCAH), which focuses on the pharmaceutical, medical technology, and healthcare services sectors. The firm provides growth capital and strategic support to companies in India, China, and Southeast Asia to help them scale regionally and globally. Its healthcare portfolio includes significant investments in medical device manufacturers, hospital networks, and pharmaceutical service providers.

Industry: Investors

Beyond the preview

Go deeper on Olympus Capital Asia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olympus Capital Asia.

Explore the full profile